CLDN18 and gastric neoplasm: The CLDN18‐ARHGAP26 gene fusion was the most frequently identified among non‐hypermutated gastric tumors in the PRH cohort, occurring in 7.7% of the samples (n = 65), with three cases located in the body and two in the antrum.